Page last updated: 2024-08-23

alovudine and Lymphoma, Mantle-Cell

alovudine has been researched along with Lymphoma, Mantle-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Buck, AK; Dechow, T; Graf, N; Herrmann, K; Keller, U; Peschel, C; Rudelius, M; Scheuerer, C; Schuster, T; Schwaiger, M; Wester, HJ	1

Trials

1 trial(s) available for alovudine and Lymphoma, Mantle-Cell

Article	Year
A pilot study to evaluate 3'-deoxy-3'-18F-fluorothymidine pet for initial and early response imaging in mantle cell lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:12 Topics: Aged; Aged, 80 and over; Biological Transport; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Lymphoma, Mantle-Cell; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Prognosis; Time Factors; Treatment Outcome	2011

Article

Year

A pilot study to evaluate 3'-deoxy-3'-18F-fluorothymidine pet for initial and early response imaging in mantle cell lymphoma.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:12

Topics: Aged; Aged, 80 and over; Biological Transport; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Lymphoma, Mantle-Cell; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Prognosis; Time Factors; Treatment Outcome

2011